The LDN Radio Show About Low Dose Naltrexone

Pharmacist John Herr talks about Low Dose Naltrexone (LDN)

Dr Armin Schwarzbach gives an update on testing for chronic illnesses.

A radio show interview with Pharmacist Mark Filosi from Medisca talks (Low Dose Naltrexone) LDN

A radio show interview with Pharmacist Suzanne Rosenberg from Community Compounding Pharmacy talks (Low Dose Naltrexone) LDN.

A radio show interview with Pharmacist Dr Dawn Ipsen from Kuslers and Clarks Pharmacies talks (Low Dose Naltrexone) LDNin a compounding pharmacy.

A radio show interview with Kimberly from the US talks (Low Dose Naltrexone) LDN for Hashimotos and Sjogren's Syndrome.

A radio show interview with Pharmacist Ray Solano from the PDLabs Compounding Pharmacy talking about compounding (Low Dose Naltrexone) LDN.

A radio show interview with Clinical Pharmacist Sebastian Denison from the PCCA talks (Low Dose Naltrexone) LDN.

Dr Steve Zielinski talks about compounding (Low Dose Naltrexone) LDN at Webster Pharmacy

Treating depression in patients with autoimmune conditions - Elizabeth Livengood NMD LDN 2019 Conference Presentation

Galyn Forster - Mental Health Issues LDN 2019 Conference

Pamela Smith, MD - LDN Use in Cognitive Decline, Lyme Disease, and Hashimoto’s Thyroiditis LDN 2019 Conference Presentation

Paul Battle PA-C - Autoimmune Hepatitis LDN 2019 Conference Presentation

Professor Angus Dalgleish LDN and immune therapy in cancer. This was a presentation at the LDN 2019 Conference.

Steve Ottersburg, MS LDN, Pain and Immunity 2019 conference presentation

Traumatic Brain Injury and LDN - Dr Sarah Zielsdorf LDN 2019 Conference Presentation

Treating depression in patients with autoimmune conditions - Elizabeth Livengood NMD 2019 LDN Conference Presentation.

Seun Moses : symptoms.wiki curator with Linda Elsegood - low dose naltrexone LDN a novel anti-inflammatory treatment

Doug from uses LDN for Ehlers-Danlos syndrome (EDS), he tells his story of having EDS as a child and how he coped.

Pharmacist Dr Sam Lebsock from Belam Pharma Solutions in the US talks about LDN and ULDN and how they spent 2 years helping to develop a test for ULDN accuracy.

Paul from the US talk about Low Dose Naltrexone (LDN) Chronic Pain, TMG, Cancer and Sleep Issues

Deena from Canada shares her Autoimmune Conditions and LDN experience.

Dr Yusuf (YP) Saleeby from the US gives an update on COVID, Long COVID and Low Dose Naltrexone (LDN)

Dr Elizabeth Livengood from AZ, US sharing her LDN Book 3 Zoom Event Low Dose Naltrexone (LDN)

Dr Paul Anderson talks about Low Dose Naltrexone (LDN) Dosing for Autoimmune Disease conditions and Cancers in Children and Adults.

Alison from the US shares her Low Dose Naltrexone (LDN) and CFS/ME amazing story

Marilyn from the US shares her Low Dose Naltrexone (LDN) and Rheumatoid Arthritis Pain (RA) Experience

Jenny from the US shares her LDN, CRPS and Small Fibre Neuropathy story with us.

Anita from the US talks about using Low Dose Naltrexone (LDN) for Multiple Sclerosis (MS)

Learn how you can improve your health.

This is Part 3 of Dr. Holtorf’s 3-part series on autoimmune thyroiditis as a core cause of hypothalamic pituitary dysfunction, mitochondrial dysfunction, obesity and systemic illness. This last segment will bring it all together and give practical ways to use this information. Dr. Holtorf discusses what further tests can be done to aid in diagnosis, when to consider nonstandard thyroid preparations, when to use straight T3, when to use T4, immune modulator therapy such as LDN and peptides, and how they're very synergistic and beneficial to prevent and reverse chronic illness.Peptides regulate most every known system in the body to be homeostatic, that may become unbalanced with illness, age, stress, chronic infection, dieting, obesity, diabetes, or any disease of aging. He talks about other labs to show immune dysfunction, and where thyroid and immune modulation is needed. He presents a study that almost all chronic fatigue syndrome and fibromyalgia patients are low thyroid despite normal thyroid function tests. Many things result in low tissue levels of thyroid, but the TSH is normal.Having low-normal thyroid has a higher risk to health than hypercholesterolemia, hypertension, diabetes, and or smoking. Several treatment approaches are given, with cautions about timed-release thyroid formulas. Case studies, and published studies are presented.

Kent Holtorf, MD, is the medical director of the Holtorf Medical Group(Holtorfmed.com) and founder and medical director of the non-profit National Academy of Hypothyroidism (NAHypothyroidism.org). He is also the founder of Integrative Peptides (IntegrativePeptides.com), dedicated to training physicians about ground-breaking peptide therapies and bringing doctors and patients the highest quality natural bioidentical peptides as supplements with unique delivery systems. Dr. Holtorf is an internationally known lecturer, author, and innovator in cutting-edge research and treatments. He has personally trained numerous physicians across the country in the use of bioidentical hormones, thyroid replacement for complex hypothyroidism syndromes, peptide therapies, immune-modulatory strategies, stem cell, exosome and growth factor treatment, hormone replacement for complex endocrine dysfunction, and innovative treatments of chronic fatigue syndrome, fibromyalgia, Lyme disease, and other chronic infectious diseases, CIRS, neurodegenerative diseases, and many others. He is a fellowship lecturer for A4M. He was the Endocrinology Expert for AOL Health and is a guest editor and peer-reviewer for the medical journals Endocrine, Postgraduate Medicine, and Pharmacy Practice. Dr. Holtorf has published many peer-reviewed endocrine reviews on complex, multisystem, poorly understood conditions. He has demonstrated that much of the long-held dogma in endocrinology and infectious disease is inaccurate. He has been a featured guest on CNBC, ABC News, CNN, Fox News (debated the Fox news medical A-team), Good Morning America, The Today Show, EXTRA TV, Discovery Health, The Learning Channel, Glenn Beck, Nancy Grace, Sean Hannity, and more and quoted in numerous print media including the Wall Street Journal, Los Angeles Times, US News and World Report, San Francisco Chronicle, WebMD, Forbes, among many others.

Dr Nasha Winters and her team discuss how they plan to facilitate a better healthcare system and how medical professionals and patients can help and take part.

Cardiologist Dr. George Yiachos answered your questions after his 90 minutes Presentation on How to Treat Chronic Inflammation to Help Prevent Heart DiseaseThis very informative presentation can be purchased from https://www.ldnrtevents.com/collections/webinars-and-training-courses

Michelle from the US shares her Chronic Pain and Low Dose Naltrexone (LDN) story with us.

This is Part 2 of Dr. Holtorf’s 3-part series on autoimmune thyroiditis as a core cause of hypothalamic pituitary dysfunction, mitochondrial dysfunction, obesity and systemic illness.Dr. Holtorf discusses how autoimmune thyroiditis is more than just a thyroid illness, it's part of a multi-system disease. He talks of how immune modulatory therapies, LDN, peptides, and other things, in addition to replacing thyroid hormone are key to fixing an underlying vicious cycle seen in so many chronic illnesses. Symptoms of low thyroid are key. He presents a symptom assessment chart, and also discusses related diseases of aging. Both decreased free T3 and elevated free T4 are independent predictors of long-term mortality risk in hospitalized chronic patients with non-thyroidal illness. According to the CDC, approximately 80% of aged individuals are afflicted by at least one chronic disease as a result of the decline of biologic related immune function

Natasha is from South Africa originally and speaks to us from Australia, sharing her experience of LDN for Chronic Pain and Cancer

Connie from the US shares her Hashimotos and Low Dose Naltrexone (LDN) Journey

Sandi in the US shares her Low Dose Naltrexone (LDN) and MS Story

Dr Lauren Deville Interviews Linda Elsegood talking about Low Dose Naltrexone

Q&As from the June Webinar on LDN: Important New Research and Therapeutic updates andDermatological Manifestations and LDNWith Clinical Compounding Pharmacists Sebastian Denison and Nat JonesPurchase the Presentations from https://www.ldnrtevents.com/collections/webinars-and-training-courses

Linda Elsegood Interview on NY Radio with Pharmacist Carol Petersen talking about her Low Dose Naltrexone (LDN) Story and the LDN Research Trust.

Tracey was diagnosed as hypothyroid after her second child was born, but Hashimoto’s wasn’t diagnosed until 3 years later when she went to a naturopath. Her fatigue improved significantly in 2 months on LDN. Last year she was diagnosed with RA, and is still working on finding the correct LDN dose. She’s on hydroxychloroquine, various supplements, and diet as well. It all helped greatly with Hashimoto's, and it basically changed her daily life, so she’s hoping that will also change her RA symptoms as well. She encourages people to try LDN; the worst thing that may happen is three months later you find it didn't work for you.Low Dose Naltrexone (LDN)

Shellie from the US takes LDN for Multiple Sclerosis and shares her story with us.

Kate from the US shares her experience of Low Dose Naltrexone, LDN, Lyme Disease, type 1 diabetes and Hashimoto's Thyroiditis.

Dr Nasha Winters talked about LDN and Health Care in The Future and her plans to make a change. This was an LDN Radio Show interview 2022.

Low Dose Naltrexone - LDN Questions Answered Live by Pharmacist Dr Masoud Rashidi - LDN Specialist. Dr Sato-Re and Dr MathewsonSponsored by Innovative Compounding Pharmacy https://icpfolsom.com

Theresa from the US share her LDN for mold and chemical sensitivity Story

Kara from the US shares her LDN and Multiple Sclerosis Journey

Kay from the United States shares her experience of LDN for Hashimoto's Thyroiditis and fibromyalgia.i4QYtplziXgS2qDZbJF9